FDA Tells 23andMe To Stop Selling Popular Genetic Test

People's genes can affect how they'll respond to blood thinners and cancer drugs. But inaccurate results can lead to bad medical decisions. Regulators are pushing back against a company that has been among the most aggressive in marketing personal genetic testing directly to consumers.